Ignite Creation Date:
2025-12-25 @ 12:13 AM
Ignite Modification Date:
2026-01-01 @ 12:19 AM
Study NCT ID:
NCT05345158
Status:
RECRUITING
Last Update Posted:
2025-12-19
First Post:
2022-03-03
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
R-RPLND as First-line Treatment for Clinical Stage IIA/B Testicular Seminoma
Sponsor:
University Health Network, Toronto
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-02-23
Start Date Type:
ACTUAL
Primary Completion Date:
2030-11
Primary Completion Date Type:
ESTIMATED
Completion Date:
2030-11
Completion Date Type:
ESTIMATED
First Submit Date:
2022-03-03
First Submit QC Date:
None
Study First Post Date:
2022-04-25
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-12-12
Last Update Post Date:
2025-12-19
Last Update Post Date Type:
ESTIMATED